Assessment of the interrelationship of prognostic factors in childhood acute lymphoblastic leukemia: A report from Childrens Cancer Study Group

Leslie L. Robison, Harland N. Sather, Peter F. Coccia, Mark E. Nesbit, G. Denman Hammond

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The pretreatment characteristics of 936 children with previously untreated acute lymphoblastic leukemia diagnosed from 1972 to 1975 were analyzed to determine their ability to predict subsequent prognosis. The patients’ treatment differed only in the type of CNS prophylaxis provided. Both univariate and multivariate analyses were performed to determine the relationship among patient characteristics and rate of remission induction, duration of initial bone marrow remission, and survival. The following patient characteristics were analyzed: initial white blood count (WBC), age at diagnosis, initial hemoglobin, initial platelet count, sex, race, pretreatment organomegaly, CNS leukemia at diagnosis, mediastinal mass, Down’s syndrome, and the type of CNS prophylaxis provided. Down’s syndrome and CNS leukemia at diagnosis were associated with a significantly lower remission induction rate. When analyzed in an univariate fashion, all factors studied, with the exception of Down’s syndrome and type of CNS prophylaxis, were significant predictors (p < 0.05) of the length of initial bone marrow remission and survival. Utilizing multivariate techniques, factors found to independently and significantly predict length of marrow remission duration were (listed in order of importance) initial WBC, sex, age at diagnosis, type of CNS prophylaxis, pretreatment nodal enlargement, initial hemoglobin, and initial platelet count.

Original languageEnglish (US)
Pages (from-to)6-14
Number of pages9
JournalAmerican Journal of Pediatric Hematology/Oncology
Volume2
Issue number1
StatePublished - Jan 1 1980

Fingerprint

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Down Syndrome
Remission Induction
Bone Marrow
Platelet Count
Neoplasms
Leukemia
Hemoglobins
Survival
Multivariate Analysis
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Assessment of the interrelationship of prognostic factors in childhood acute lymphoblastic leukemia : A report from Childrens Cancer Study Group. / Robison, Leslie L.; Sather, Harland N.; Coccia, Peter F.; Nesbit, Mark E.; Hammond, G. Denman.

In: American Journal of Pediatric Hematology/Oncology, Vol. 2, No. 1, 01.01.1980, p. 6-14.

Research output: Contribution to journalArticle

Robison, Leslie L. ; Sather, Harland N. ; Coccia, Peter F. ; Nesbit, Mark E. ; Hammond, G. Denman. / Assessment of the interrelationship of prognostic factors in childhood acute lymphoblastic leukemia : A report from Childrens Cancer Study Group. In: American Journal of Pediatric Hematology/Oncology. 1980 ; Vol. 2, No. 1. pp. 6-14.
@article{6ef84868a2bc4797acf31cb270d60eab,
title = "Assessment of the interrelationship of prognostic factors in childhood acute lymphoblastic leukemia: A report from Childrens Cancer Study Group",
abstract = "The pretreatment characteristics of 936 children with previously untreated acute lymphoblastic leukemia diagnosed from 1972 to 1975 were analyzed to determine their ability to predict subsequent prognosis. The patients’ treatment differed only in the type of CNS prophylaxis provided. Both univariate and multivariate analyses were performed to determine the relationship among patient characteristics and rate of remission induction, duration of initial bone marrow remission, and survival. The following patient characteristics were analyzed: initial white blood count (WBC), age at diagnosis, initial hemoglobin, initial platelet count, sex, race, pretreatment organomegaly, CNS leukemia at diagnosis, mediastinal mass, Down’s syndrome, and the type of CNS prophylaxis provided. Down’s syndrome and CNS leukemia at diagnosis were associated with a significantly lower remission induction rate. When analyzed in an univariate fashion, all factors studied, with the exception of Down’s syndrome and type of CNS prophylaxis, were significant predictors (p < 0.05) of the length of initial bone marrow remission and survival. Utilizing multivariate techniques, factors found to independently and significantly predict length of marrow remission duration were (listed in order of importance) initial WBC, sex, age at diagnosis, type of CNS prophylaxis, pretreatment nodal enlargement, initial hemoglobin, and initial platelet count.",
author = "Robison, {Leslie L.} and Sather, {Harland N.} and Coccia, {Peter F.} and Nesbit, {Mark E.} and Hammond, {G. Denman}",
year = "1980",
month = "1",
day = "1",
language = "English (US)",
volume = "2",
pages = "6--14",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Assessment of the interrelationship of prognostic factors in childhood acute lymphoblastic leukemia

T2 - A report from Childrens Cancer Study Group

AU - Robison, Leslie L.

AU - Sather, Harland N.

AU - Coccia, Peter F.

AU - Nesbit, Mark E.

AU - Hammond, G. Denman

PY - 1980/1/1

Y1 - 1980/1/1

N2 - The pretreatment characteristics of 936 children with previously untreated acute lymphoblastic leukemia diagnosed from 1972 to 1975 were analyzed to determine their ability to predict subsequent prognosis. The patients’ treatment differed only in the type of CNS prophylaxis provided. Both univariate and multivariate analyses were performed to determine the relationship among patient characteristics and rate of remission induction, duration of initial bone marrow remission, and survival. The following patient characteristics were analyzed: initial white blood count (WBC), age at diagnosis, initial hemoglobin, initial platelet count, sex, race, pretreatment organomegaly, CNS leukemia at diagnosis, mediastinal mass, Down’s syndrome, and the type of CNS prophylaxis provided. Down’s syndrome and CNS leukemia at diagnosis were associated with a significantly lower remission induction rate. When analyzed in an univariate fashion, all factors studied, with the exception of Down’s syndrome and type of CNS prophylaxis, were significant predictors (p < 0.05) of the length of initial bone marrow remission and survival. Utilizing multivariate techniques, factors found to independently and significantly predict length of marrow remission duration were (listed in order of importance) initial WBC, sex, age at diagnosis, type of CNS prophylaxis, pretreatment nodal enlargement, initial hemoglobin, and initial platelet count.

AB - The pretreatment characteristics of 936 children with previously untreated acute lymphoblastic leukemia diagnosed from 1972 to 1975 were analyzed to determine their ability to predict subsequent prognosis. The patients’ treatment differed only in the type of CNS prophylaxis provided. Both univariate and multivariate analyses were performed to determine the relationship among patient characteristics and rate of remission induction, duration of initial bone marrow remission, and survival. The following patient characteristics were analyzed: initial white blood count (WBC), age at diagnosis, initial hemoglobin, initial platelet count, sex, race, pretreatment organomegaly, CNS leukemia at diagnosis, mediastinal mass, Down’s syndrome, and the type of CNS prophylaxis provided. Down’s syndrome and CNS leukemia at diagnosis were associated with a significantly lower remission induction rate. When analyzed in an univariate fashion, all factors studied, with the exception of Down’s syndrome and type of CNS prophylaxis, were significant predictors (p < 0.05) of the length of initial bone marrow remission and survival. Utilizing multivariate techniques, factors found to independently and significantly predict length of marrow remission duration were (listed in order of importance) initial WBC, sex, age at diagnosis, type of CNS prophylaxis, pretreatment nodal enlargement, initial hemoglobin, and initial platelet count.

UR - http://www.scopus.com/inward/record.url?scp=84930879606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930879606&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84930879606

VL - 2

SP - 6

EP - 14

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 1

ER -